Peter Burch work email
- Valid
- Valid
- Valid
Peter Burch personal email
Cell and molecular biologist with extensive research experience in small-molecule and biotherapeutic drug development. Project team leader with expertise in preclinical research and biomarker development for metabolic and rare muscle diseases.
-
Sarepta TherapeuticsSarepta TherapeuticsBoston, Ma, Us
-
Director, Nonclinical PharmacologySarepta Therapeutics Mar 2020 - PresentCambridge, Ma, UsResearch team lead supporting the nonclinical development of genetic medicines for Duchenne muscular dystrophy and other muscular disorders.
-
Associate Director, Translational SciencesSarepta Therapeutics Nov 2018 - Mar 2020Cambridge, Ma, Us
-
Director Of BiologySummit Therapeutics Plc Apr 2017 - Aug 2018Miami, Florida, UsResearch project leader directing the efforts of a multidisciplinary biology team to discover and develop novel clinical candidates for Duchenne muscular dystrophy. -
Senior Principal ScientistPfizer May 2014 - Jan 2017New York, New York, UsApplied molecular, biochemical and fluorescence imaging approaches to develop therapeutics and identify biomarkers for metabolic and rare muscle disorders. Designed and conducted in vitro and in vivo pharmacology studies for preclinical and translational biomarker discovery projects. Led a multi-disciplinary academic collaboration that identified biomarkers of disease progression for rare muscle disorder programs. -
Principal ScientistPfizer May 2011 - Apr 2014New York, New York, Us
-
Senior ScientistPfizer Jun 2008 - Apr 2010New York, New York, Us
-
Postdoctoral FellowYale University School Of Medicine Sep 2004 - May 2008New Haven, Ct, UsStudied the gene expression and cell signaling pathways that regulate skeletal muscle growth and regeneration using in vivo and primary cell culture models. Demonstrated a novel role for the regulation of the calceneurin/NFAT pathway by the tyrosine phosphatase SHP-2 to promote skeletal muscle growth and fiber type switching. Identified a role for mutations in SHP-2 in the activation of calcium influx and cardiomyocyte hypertrophy in the rare disease Noonan Syndrome. -
Graduate Research FellowUniversity Of Vermont Sep 1998 - Jun 2004Burlington, Vermont, UsInvestigated the role of the MAP kinase signaling pathway in regulating gene expression and cell proliferation. -
Research AssociateRepligen Corporation 1996 - 1998Waltham, Ma, UsDeveloped and performed assays for small-molecule inhibitors of angiogenesis for use as cancer therapeutics. -
Research AssociateCytomed Inc 1992 - 1995Developed and performed assays for inhibitors of inflammation
Peter Burch Skills
Peter Burch Education Details
-
University Of VermontCell And Molecular Biology -
University Of New HampshireMicrobiology And Immunology
Frequently Asked Questions about Peter Burch
What company does Peter Burch work for?
Peter Burch works for Sarepta Therapeutics
What is Peter Burch's role at the current company?
Peter Burch's current role is Sarepta Therapeutics.
What is Peter Burch's email address?
Peter Burch's email address is pe****@****zer.com
What schools did Peter Burch attend?
Peter Burch attended University Of Vermont, University Of New Hampshire.
What skills is Peter Burch known for?
Peter Burch has skills like Biomarkers, Cell, Cell Biology, Cell Signaling, Western Blotting, Molecular Biology, Animal Models, Elisa, Biochemistry, Fluorescence, Drug Development, Drug Discovery.
Who are Peter Burch's colleagues?
Peter Burch's colleagues are Shashikiran P., Sarvan Kumar, Gaurav Dwivedi, Torey Braverman, Erin Burke, Zachary Schneiderman, Shannon Lebel.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial